There was a study that suggests that people who suffer from bipolar disorder have a higher risk of Parkinson’s disease. My very first thought was that, well, many people who are diagnosed with bipolar are given psychiatric drugs, and I have no doubt that those drugs, those synthetic chemicals, are contributing to people developing neurological problems, including Parkinson’s. (The drugs are a major, #1 priority with today’s damned psychiatrists, so it seems!)
Some snips from the study, according to Medpage Today:
The trend was significant even in adults younger than age 65, and the frequency of psychiatric admissions for manic/mixed and depressive episodes correlated with Parkinson’s risk.
What Parkinson’s and bipolar disorder share is unclear, but “could include genetic alterations, inflammatory processes, or problems with the transmission of messages between brain cells,” he suggested.
That were caused by the damn psychiatric drugs? Ya think?
“If we could identify the underlying cause of this relationship, that could potentially help us develop treatments that could benefit both conditions.”
How about just getting rid of Big Pharma poison? But no, we have to “develop more treatments” so that the pharmaceutical companies especially the execs can fatten their bank accounts!
Toward the end, the article notes:
And despite controlling for antipsychotic drugs, the risk that some Parkinson’s disease identified in this study was actually drug-induced parkinsonism remains a possibility, they added.
However, according to Dr. Peter Breggin, my favorite psychiatrist (if I have to have a “favorite psychiatrist”),
Antipsychotic drugs, including both older and newer ones, cause shrinkage (atrophy) of the brain in many human brain scan studies and in animal autopsy studies…Many studies of SSRIs show severe brain abnormalities, such as shrinkage (atrophy) with brain cell death in humans and the growth of new abnormal brain cells in animal and laboratory studies.. Benzos deteriorate memory and other mental capacities. Human studies demonstrate that they frequently lead to atrophy and dementia after longer-term exposure. After withdrawal, individuals exposed to these drugs also experience multiple persisting problems including memory and cognitive dysfunction, emotional instability, anxiety, insomnia, and muscular and neurological discomforts…
So, this Parkinson’s-bipolar study is just another “study,” in my opinion, that rationalizes more drugs for more people to make people worse off than the first drugs made them previously.